相关实验视频

Updated: Jun 13, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

在乳腺癌精准医学时代,优化生物标志物评估和分子测试

David G Hicks¹, Bradley M Turner¹

¹Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.

Biotechnic & histochemistry : official publication of the Biological Stain Commission

|September 11, 2024

概括

精准医学通过分子瘤检测改变了癌症护理. 确保标准化的预分析因子对于准确的诊断和乳腺癌患者的有效治疗至关重要.

科学领域:

在瘤学瘤学.
病理学病理学病理学
分子生物学分子生物学

背景情况:

精准医学通过整合分子瘤生物学和先进诊断技术,彻底改变了癌症护理.
这种方法根据个体患者的瘤形状和分子驱动因素来定制治疗决策.
病理学在提供精准医学方面发挥着至关重要的作用,需要对组织样本进行仔细处理.

研究的目的:

突出精准医学对病理学实践的影响.
强调标准化预分析因子对分子测试质量的重要性.
讨论当前分子测试在乳腺癌护理中的现状.

主要方法:

精准医学和病理学当前实践的审查.
分析分析前变量对分子测试的影响.
讨论已建立的生物标志物 (激素受体,HER2) 和新兴的基因表达特征.

主要成果:

在分析前的因素中缺乏标准化,可能会损害组织样本的质量.
受损的样本质量会对下游生物标志物和分子测试产生负面影响.
不一致的分析前工作流程最终会影响患者的护理和治疗结果.

结论:

分析前因素的标准化对于精密瘤学中可靠的分子测试至关重要.
病理学家和临床界必须确保诊断的准确性,以获得最佳的患者治疗.
坚持组织处理的最佳实践对于精准医学在乳腺癌中的成功至关重要.

关键词:

生物标志物生物标志物乳腺癌乳腺癌乳腺癌分子测试试验分子测试精准医学是一门精准医学.

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...